Preclinical Pharmacological Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.
第一作者:
Adam,Rolt
第一单位:
Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
作者:
医学主题词
动物(Animals);抗病毒药(Antiviral Agents);癌, 肝细胞(Carcinoma, Hepatocellular);细胞系(Cell Line);基因型(Genotype);肝炎病毒属(Hepacivirus);丙型肝炎, 慢性(Hepatitis C, Chronic);肝细胞(Hepatocytes);人类(Humans);肝硬化(Liver Cirrhosis);肝肿瘤(Liver Neoplasms);男(雄)性(Male);小鼠(Mice);小鼠, SCID(Mice, SCID);哌嗪类(Piperazines);病毒内化(Virus Internalization)
DOI
10.1093/infdis/jiy039
PMID
29373739
发布时间
2019-09-06
- 浏览8
The Journal of infectious diseases
1761-1769页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



